Safety and Efficacy Study of LJP 394 (Abetimus Sodium) to Treat Lupus Kidney Disease

This study has been completed.
Sponsor:
Information provided by:
La Jolla Pharmaceutical Company
ClinicalTrials.gov Identifier:
NCT00035308
First received: May 2, 2002
Last updated: September 22, 2006
Last verified: December 2002
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: December 2002
  Estimated Primary Completion Date: No date given
No publications provided by La Jolla Pharmaceutical Company

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):